Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases

铁依赖性双加氧酶对 mRNA 去甲基化的选择性和调节

• 批准号: 10438887
• 负责人: Jeffrey Scott Mugridge
• 金额: $ 39.16万
• 依托单位: UNIVERSITY OF DELAWARE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-08-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10438887
• 关键词: Acute Myelocytic Leukemia; Ascorbic Acid; Biochemistry; Bioinorganic Chemistry; Biological; Biology; Cells; Cellular biology; Chemicals; Dioxygenases; Disease; Enzymes; Family; Family member; Glioblastoma; Goals; Human; Iron; Link; Malignant Neoplasms; Mammalian Cell; Maps; Messenger RNA; Modification; Molecular; Monitor; Pathway interactions; Play; RNA; RNA methylation; Regulation; Research; Role; Structure; Transcript; cofactor; demethylation; human disease; insight; mRNA capping; novel; novel strategies; overexpression; programs; structural biology; therapeutic target; tool; transcriptome; tumor growth; tumor progression; tumorigenesis

TITLE: Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases ABSTRACT: The long-term goals of this research program are to (1) define the structural and molecular mechanisms that control the selectivity and function of RNA demethylase enzymes, (2) develop new chemical tools to monitor RNA demethylation in cells, and (3) understand how the key cofactor ascorbic acid interacts with RNA demethylases and other iron-dependent dioxygenase family members to regulate their activity. Methyl modifications on mRNA tune transcript function, are essential for mammalian cell fate decisions, and play important roles in the progression of many human cancers. The iron-dependent dioxygenase enzymes FTO and AlkBH5 act as ‘erasers’ of highly abundant N6-methyladenosine (m6A) modifications found in the mRNA body and, in the case of FTO, N6,2’-O-dimethyladenosine (m6Am) modifications found on the 5’ mRNA cap. These RNA demethylases are overexpressed in cancers including glioblastoma and acute myeloid leukemia, where increased demethylation activity and reduced methyl modification levels promote tumorigenesis and cancer progression. Despite these clear links to human disease, we currently have a poor understanding of how FTO and AlkBH5 recognize their biological substrates, which mRNA transcripts are targeted for demethylation, and how demethylation influences mRNA function. Furthermore, FTO and AlkBH5 belong to the non-heme iron(II) and -ketoglutarate-dependent family of dioxygenases that require ascorbic acid (vitamin C) as a cofactor for efficient activity, but we have almost no structure-level insights into how ascorbic acid interacts with this diverse family of enzymes and how this physical interaction may potentiate dioxygenase activity in cells. This proposal combines approaches from biochemistry, structural biology, chemical biology, bioinorganic chemistry, and cell biology to determine the structural basis for RNA demethylase selectivity, develop novel probes to map demethylation targets across the transcriptome, and quantify and visualize the dioxygenase-ascorbic acid interaction to understand how this cofactor regulates enzymatic activity. The results from these proposed studies will significantly enhance our understanding of how cellular mRNA demethylation is regulated in cells and pave the way for therapeutics that target demethylation pathways in challenging cancers such as glioblastoma.

铁依赖双加氧酶对信使核糖核酸去甲基化的选择性和调节 摘要：这项研究计划的长期目标是(1)确定结构和 控制RNA脱甲基酶选择性和功能的分子机制，(2) 开发新的化学工具来监测细胞中的RNA去甲基化，以及(3)了解 关键辅助因子抗坏血酸与RNA去甲基酶和其他铁依赖的相互作用 双加氧酶家族成员调节他们的活动。信使核糖核酸的甲基化修饰 转录功能，对哺乳动物细胞命运的决定是必不可少的，并在 许多人类癌症的进展。铁依赖的双加氧酶FTO和FTO AlkBH5作为高度丰富的N6-甲基腺苷(M6A)修饰的“擦除器”，在 MRNA体，在FTO的情况下，N6，2‘-O-二甲基腺苷(M6Am)修饰发现在 5‘mRNA帽。这些RNA去甲基酶在包括胶质母细胞瘤在内的癌症中过度表达 和急性髓系白血病，其中去甲基化活性增加，甲基减少 修饰水平促进肿瘤的发生和癌症的进展。尽管有这些明确的链接， 人类疾病，我们目前对FTO和AlkBH5如何识别他们的 生物底物，哪些信使核糖核酸转录物是去甲基化的靶标，以及如何 去甲基化影响信使核糖核酸功能。此外，FTO和AlkBH5属于非血红素 铁(II)和-酮戊二酸依赖的双加氧酶家族，需要抗坏血酸(维生素 C)作为有效活动的辅助因素，但我们几乎没有结构层面的洞察力 抗坏血酸与这种不同的酶家族相互作用，以及这种物理相互作用如何 增强细胞中的双加氧酶活性。这项提议结合了生物化学的方法， 结构生物学、化学生物学、生物无机化学和细胞生物学 RNA去甲基酶选择性的结构基础，开发新的探针来定位去甲基化 整个转录组的靶点，并量化和可视化双加氧酶-抗坏血酸 相互作用，以了解这种辅因子如何调节酶的活性。这些研究的结果 拟议中的研究将显著增强我们对细胞mRNA如何 去甲基化在细胞中被调节，并为靶向去甲基化的治疗铺平了道路 挑战胶质母细胞瘤等癌症的途径。